Preventative Strategies for Early-Onset Bipolar Disorder

McNamara, Robert K.; Nandagopal, Jayasree J.; Strakowski, Stephen M.; DelBello, Melissa P.
December 2010
CNS Drugs;2010, Vol. 24 Issue 12, p983
Academic Journal
Bipolar disorder is a chronic and typically recurring illness with significant psychosocial morbidity. Although the aetiological factors that contribute to the onset of mania, and by definition bipolar I disorder, are poorly understood, it most commonly occurs during the adolescent period. Putative risk factors for developing bipolar disorder include having a first-degree relative with a mood disorder, physicallsexual abuse and other psychosocial stressors, substance use disorders, psychostimulant and antidepressant medication exposure and omega-3 fatty acid deficiency. Prominent prodromal clinical features include episodic symptoms of depression, anxiety, hypomania, anger/irritability and disturbances in sleep and attention. Because prodromal mood symptoms precede the onset of mania by an average of 10 years, and there is low specificity of risk factors and prodromal features for mania, interventions initiated prior to onset of the disorder (primary prevention) or early in the course of the disorder (early or secondary prevention) must be safe and well tolerated upon long-term exposure. Indeed, antidepressant and psychostimulant medications may precipitate the onset of mania. Although mood stabilizers and atypical antipsychotic medications exhibit efficacy in youth with bipolar I disorder, their efficacy for the treatment of prodromal mood symptoms is largely unknown. Moreover, mood stabilizers and atypical antipsychotics are associated with prohibitive treatment-emergent adverse effects. In contrast, omega-3 fatty acids have neurotrophic and neuroprotective properties and have been found to be efficacious, safe and well tolerated in the treatment of manic and depressive symptoms in children and adolescents. Together, extant evidence endorses a clinical staging model in which subjects at elevated risk for developing mania are treated with safer interventions (i.e. omega-3 fatty acids, family-focused therapy) in the prodromal phase, followed by pharmacological agents with potential adverse effects for nonresponsive cases and secondary prevention. This approach warrants evaluation in prospective longitudinal trials in youth determined to be at ultra-high risk for bipolar I disorder.


Related Articles

  • Folate and Fish Might Protect Your Hearing.  // Tufts University Health & Nutrition Letter;Oct2010, Vol. 28 Issue 8, p1 

    The article presents the findings of the Blue Mountains Hearing Study conducted on preventing hearing loss in the U.S. The study reveals that hearing loss is the most common sensory disorder in the nation and has effected more than 36 million Americans. It reports that the consumption of folic...

  • More Data on Omega 3s & Retinal Health.  // Review of Ophthalmology;Apr2011, Vol. 18 Issue 4, p13 

    The article reports on the result of the study conducted on mice revealing the process of how omega-3 fatty acids prevents blindness.

  • 0mega-3s vs. Gum Disease.  // Tufts University Health & Nutrition Letter;Jan2011, Vol. 28 Issue 11, p3 

    The article focuses on a study, published in the "Journal of the American Dietetic Association," according to which omega-3 fatty acids might also be good for teeth and gums.

  • Omega-3s Might Help Protect Against Muscle Loss with Aging.  // Tufts University Health & Nutrition Letter;Jun2011, Vol. 29 Issue 4, p6 

    No abstract available.

  • Extra Omega-3s Shown to Improve Insulin Resistance.  // Tufts University Health & Nutrition Letter;Oct2011, Vol. 29 Issue 8, p8 

    The article discusses an Italian clinical trial which revealed that consumption of the omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), three times a day for three months improved the markers of insulin resistance in participants.

  • Moderate Fish Intake Reduces Ischemic Stroke Risk in Men. Wellbery, Caroline // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1081 

    Describes a study that examined whether eating fish or supplementation with long-chain omega-3 polyunsaturated fatty acids reduces the risk of ischemic stroke but not hemorrhagic stroke in men. Effects of consumption of fish on the risk of ischemic stroke and hemorrhagic stroke; Comparison of...

  • n-3 Fatty acids prevent whereas trans-fatty acids induce vascular inflammation and sudden cardiac death. Siddiqui, Rafat A.; Harvey, Kevin A.; Ruzmetov, Nargiz; Miller, Steven J.; Zaloga, Gary P. // British Journal of Nutrition;2009, Vol. 102 Issue 12, p1811 

    n-3 PUFA have well-recognised cardio-beneficial effects. In contrast, premature coronary deaths are associated with consumption of high levels of trans-fatty acids (TFA). The present study determined the effects of n-3 PUFA and TFA on sudden cardiac death and vascular inflammation. A rat...

  • Dietary interventions with n-3 fatty acids or probiotics targeting post-myocardial infarction depression. Siddiqui, Rafat A.; Harvey, Kevin A. // British Journal of Nutrition;Jan2013, Vol. 109 Issue 1, p1 

    The author comments on a study by Gilbert and colleagues exploring the effectiveness of dietary supplementation with n-3 fatty acids or probiotics in a rat model for gradual loss in intensity of post-myocardial infarction (MI) depression. He discusses the role of n-3 fatty acids in depression...

  • n-3 Fatty acids and prostate cancer risk. Brasky, Theodore M.; Crowe, Francesca L.; Kristal, Alan R. // British Journal of Nutrition;11/14/2012, Vol. 108 Issue 9, p1721 

    A letter to the editor is presented in response to the article "Omega-3 fatty acids and cancers: a systematic update of epidemiological studies" by M. Gerber in the June 2012 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics